Thoratec is a leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts.
"Bill brings tremendous skills, leadership and experience to the Thoratec team, and we are delighted to add him to our board of directors," said Neil F. Dimick, chairman of Thoratec's board of directors.
Gary F. Burbach, the company's president and CEO, added: "Bill has been a leader in the healthcare industry for over three decades. We are confident that his industry knowledge, strategic insight and depth of experience, spanning from technology innovation to market development to broader healthcare policy, will be of great value to Thoratec."
Hawkins currently serves as president and chief executive officer of Immucor Inc. and as a senior advisor to TPG Capital. Previously, he held a number of senior executive positions at Medtronic Inc., including the role of chairman and chief executive officer. Earlier, he was the CEO of Novoste Corp. and held leadership positions at American Home Products, Eli Lilly, Johnson & Johnson and Guidant. Additionally, he has served on a number of corporate and nonprofit boards of directors.
"I am excited to join the Thoratec board," Hawkins said. "Thoratec has a rich history of innovation and leadership in the mechanical circulatory support industry, and I look forward to participating in the company's mission of driving greater adoption of its therapies in order to deliver meaningful benefits to patients worldwide."
Hawkins' appointment will be effective as of Jan. 1, bringing the number of the company's directors to nine. For more information, visit the company's website at www.thoratec.com.